Optimizing the Delivery of Cancer Drugs That Block Angiogenesis

See allHide authors and affiliations

Science Translational Medicine  20 Jan 2010:
Vol. 2, Issue 15, pp. 15ps3
DOI: 10.1126/scitranslmed.3000399

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Drugs that block angiogenesis are important components of first-line therapies for a number of human cancers. However, some of these agents have undesirable effects on the patient. Optimal delivery systems must be developed to maximize clinical benefits and minimize adverse effects in cancer patients. In this Perspective, we discuss these drug-related issues and propose ways to optimize antiangiogenic therapy by the development of new drug delivery systems.


  • Citation: Y. Cao and R. Langer, Optimizing the delivery of cancer drugs that block angiogenesis. Sci. Transl. Med. 2, 15ps3 (2010).

View Full Text

Stay Connected to Science Translational Medicine